Coagulation factor VII

Coagulation factor VII信息

英文名称:Coagulation factor VII上市药物数量21
中文名称凝血因子VII临床药物数量10
靶点别称EC 3.4.21,Eptacog alfa,F7,Coagulation Factor VII,Coagulation Factor VII (Serum Prothrombin Conversion Accelerator),FVII Coagulation Protein,SPCA,EC 3.4.21.21,Factor VII,Proconvertin,Serum prothrombin conversion accelerator,EC:3.4.21.21最高研发阶段批准上市
英文名称:Coagulation factor VII
中文名称凝血因子VII
靶点别称EC 3.4.21,Eptacog alfa,F7,Coagulation Factor VII,Coagulation Factor VII (Serum Prothrombin Conversion Accelerator),FVII Coagulation Protein,SPCA,EC 3.4.21.21,Factor VII,Proconvertin,Serum prothrombin conversion accelerator,EC:3.4.21.21
上市药物数量21
临床药物数量10
最高研发阶段Approved

Coagulation factor VII产品列表

  • 属性

    Protein (2)

  • 产品库

    在线 (2)

  • 物种

    Human (1)Mouse (1)

  • 标签

    His Tag (2)

  • 标记

    Unconjugated (2)

共 2 项数据
  • 1

Coagulation factor VII分子背景

Coagulation factor VII is also known as F7, SPCA and Proconvertin. Heterodimer of a light chain and a heavy chain linked by a disulfide bond. Initiates the extrinsic pathway of blood coagulation. Serine protease that circulates in the blood in a zymogen form. Factor VII is converted to factor VIIa by factor Xa, factor XIIa, factor IXa, or thrombin by minor proteolysis. In the presence of tissue factor and calcium ions, factor VIIa then converts factor X to factor Xa by limited proteolysis. Factor VIIa will also convert factor IX to factor IXa in the presence of tissue factor and calcium.

Coagulation factor VII分子别名

Coagulation factor VII,F7,SPCA,Proconvertin
  • 分子信息
  • 产品列表